Actively Recruiting
Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates
Led by Alexandria University · Updated on 2026-01-16
120
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.
CONDITIONS
Official Title
Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Preterm neonates born at or before 32 weeks gestational age
- Feeding started within the first 72 hours of life
- Parental consent given
You will not qualify if you...
- Lack of parental consent or refusal to participate
- Presence of major congenital abnormalities
- Infants older than 72 hours at the time of enrollment
- Feeding not started within the first 3 days of life
- Known diagnosis of galactosemia
- Severe intrauterine growth restriction (IUGR)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Marwa Mohamed Farag
Alexandria, Egypt, 0325
Actively Recruiting
Research Team
M
Marwa M Farag, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here